FDC

FDC share price & financials

Price
₹420.1
Market cap
₹5.6k Cr
Sector
Healthcare

What FDC Limited does

FDC Limited is an India-based pharmaceutical company that develops, manufactures and markets branded generic formulations, active pharmaceutical ingredients (APIs) and nutraceuticals. Its domestic portfolio spans anti-infectives, gastrointestinal, ophthalmic, cardiovascular, anti-diabetic, dermatology, paediatric and vitamin/mineral/nutraceutical therapy areas, sold through its own field force to doctors and pharmacies. It also manufactures APIs in-house to backward-integrate its formulation business, and exports formulations and APIs to markets across Europe, Africa, the Middle East and Asia-Pacific, with a separate US-focused generics filing pipeline.

Segments

  • Domestic Formulations
  • Export/International Formulations
  • API
Manufacturing facilities
7 plants across India (6 formulation + 1 API)
Manufacturing locations
Roha (API), Waluj, Goa I, Goa II, Goa III, Sinnar, Baddi
Countries served
50+ countries across Europe, Africa, APAC and the Middle East
Products registered internationally
401 products registered across 51 countries
Domestic field force
~4,800-strong field force calling on doctors
In-house R&D centres
2 (Jogeshwari and Kandivali, Mumbai)
Founded 1936Headquarters Mumbai, Maharashtra, IndiaEmployees 6,000 (2023-09-30) Company website

Quarterly results

Q1 FY27: revenue up 2.0%, net profit up 8.2% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue505 459 482 642 462 −9%458 −0%564 +17%655 +2%
EBITDA72 46 53 141 35 −51%50 +9%112 +111%143 +1%
Net profit74 36 48 122 29 −61%27 −25%107 +123%132 +8%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −25.8% 1Y

₹350₹400₹450₹500Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26

1Y: ₹459.95 on 10 Sept 2025 → ₹341.45. High ₹486.85 (19 Sept 2025), low ₹321.1 (27 Mar 2026).

Financials, as filed

Revenue grew 6.0% a year over 3 years, FY23 to FY26. Operating margin widened to 15.9%.

Year endingFY23FY24FY25FY26
Revenue₹1.8k Cr₹1.9k Cr₹2.1k Cr₹2.1k Cr
Operating profit₹243 Cr₹339 Cr₹313 Cr₹338 Cr
Operating margin13.6%17.7%15.1%15.9%
Interest₹4 Cr₹4 Cr₹4 Cr₹5 Cr
Depreciation₹39 Cr₹40 Cr₹54 Cr₹59 Cr
Net profit₹195 Cr₹307 Cr₹273 Cr₹285 Cr
Net margin10.9%16.0%13.2%13.4%
Cash from operations₹165 Cr₹221 Cr₹310 Cr₹200 Cr
Free cash flow₹54 Cr₹151 Cr₹220 Cr₹40 Cr
ROCE13.0%18.0%16.0%15.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹17 Cr₹17 Cr₹17 Cr₹16 Cr₹16 Cr₹16 Cr
Reserves₹1.7k Cr₹1.9k Cr₹2.0k Cr₹2.1k Cr₹2.4k Cr₹2.5k Cr
Borrowings₹14 Cr₹31 Cr₹28 Cr₹20 Cr₹21 Cr₹15 Cr
Other liabilities₹207 Cr₹274 Cr₹327 Cr₹341 Cr₹433 Cr₹404 Cr
Total liabilities₹1.9k Cr₹2.3k Cr₹2.3k Cr₹2.5k Cr₹2.9k Cr₹2.9k Cr
Fixed assets₹685 Cr₹701 Cr₹695 Cr₹676 Cr₹842 Cr₹994 Cr
Capital work in progress₹19 Cr₹104 Cr₹198 Cr₹261 Cr₹163 Cr₹96 Cr
Investments₹790 Cr₹886 Cr₹806 Cr₹850 Cr₹1.0k Cr₹1.1k Cr
Other assets₹448 Cr₹563 Cr₹637 Cr₹672 Cr₹874 Cr₹752 Cr
Total assets₹1.9k Cr₹2.3k Cr₹2.3k Cr₹2.5k Cr₹2.9k Cr₹2.9k Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, the public added +1.87 pp while FIIs trimmed −1.01 pp. The shareholder count grew 1% to 55,045.

Promoters
69.7%
FIIs
1.4%
DIIs
6.3%
Public
22.6%

Since Jun 2025

  • Public +1.87 pp
  • FIIs −1.01 pp
  • DIIs −0.86 pp

How it drifted, 12 quarters

Over this window the public went from 19.8% to 22.6% — +2.8 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 69.7%, FIIs 2.4%, DIIs 8.1%, Public 19.8%.Dec '23: Promoters 69.7%, FIIs 2.4%, DIIs 7.8%, Public 20.1%.Mar '24: Promoters 69.7%, FIIs 2.6%, DIIs 6.9%, Public 20.8%.Jun '24: Promoters 69.7%, FIIs 2.5%, DIIs 6.7%, Public 21.1%.Sep '24: Promoters 69.7%, FIIs 2.6%, DIIs 6.0%, Public 21.7%.Dec '24: Promoters 69.7%, FIIs 2.7%, DIIs 6.1%, Public 21.6%.Mar '25: Promoters 69.7%, FIIs 2.6%, DIIs 6.4%, Public 21.4%.Jun '25: Promoters 69.7%, FIIs 2.4%, DIIs 7.2%, Public 20.8%.Sep '25: Promoters 69.7%, FIIs 2.4%, DIIs 6.8%, Public 21.1%.Dec '25: Promoters 69.7%, FIIs 2.3%, DIIs 6.3%, Public 21.8%.Mar '26: Promoters 69.7%, FIIs 2.4%, DIIs 6.3%, Public 21.6%.Jun '26: Promoters 69.7%, FIIs 1.4%, DIIs 6.3%, Public 22.6%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 2 holders trimming and 1 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of FDC Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Mutual funds in FDC

Filings to Aug 2026

0 new, 0 added, 0 trimmed, 0 sold out — net +0.00 L shares (+0.0%).

Held by funds
₹144 Cr
1 schemes
Biggest holder
Nippon India Small Cap Fund
₹144 Cr · 0.2% of that fund
SchemeHoldingLast month
Nippon India Small Cap Fund Nippon India Mutual Fund₹144 Crheld

HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.

Mutual funds Aug 2026

0 added, 0 trimmed — net 0 shares (+0.0%)

Funds are sitting on
+123%
vs est. average cost
Held by funds
₹144 Cr
1 schemes · ≈ 3.2% of the company

Shares held by these funds −5%

Aug '23 42.75 L shares Jul '26

What the price assumes

Fair

To justify its price of ₹341, this stock must grow earnings at 15% every year for 7 years. Our analysis caps realistic growth at ~15%. At that growth it is worth ₹339 — downside of 1%.

Growth the price implies
14.7% a year
for 7 years, fading to 4%
It has actually compounded at
13.5% a year
net profit, FY23–FY26 · EPS 14.5%
The gap
0.0 pp
-1% downside if it only repeats history
Price today ₹341.45 Value at the reference growth ₹338.96

Change the assumptions yourself →